@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix go: . @prefix obo: . @prefix occursIn: . @prefix do: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 rdf:object go:0008283; rdf:predicate belv:increases; rdf:subject schem:7-%283-%283-Hydroxy-4-%284%27-iodophenoxy%29-1-butenyl%29-7-oxabicyclo%282.2.1%29heptan-2-yl%29-5-heptenoic%20acid; a rdf:Statement . sub:_2 occursIn: do:1324, obo:EFO_0003118, species:9606; rdf:object sub:_1; rdf:predicate belv:decreases; rdf:subject schem:SQ%2029548; a rdf:Statement . sub:assertion rdfs:label "a(SCHEM:\"7-(3-(3-Hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid\") -> bp(GOBP:\"cell proliferation\")", "a(SCHEM:\"SQ 29548\") -| (a(SCHEM:\"7-(3-(3-Hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid\") -> bp(GOBP:\"cell proliferation\"))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "20131211" . sub:_3 prov:value "Figure 6A indicated that I-BOP stimulated H157 cell proliferation in a dose-dependent manner as determined by thymidine uptake...I-BOP-stimulated cell proliferation was fully blocked by a TP antagonist, SQ29548, indicating that it was a TP-mediated event (Figure 6B)."; prov:wasQuotedFrom pubmed:19570744 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:19570744; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:34.912+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }